Evidence map›Paper›PMID 30138345›Full record

ArticlePloS one2018

Age-related differences in the clinical features of ocular sarcoidosis.

Kei Takayama, Kozo Harimoto, Tomohito Sato, Yutaka Sakurai, Manzo Taguchi, Takayuki Kanda, Masaru Takeuchi

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 12 citations in OpenAlex.

  1. Burden of macular complications in Japanese patients aged 75 years and over with sarcoid uveitis.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2025
    Article
  2. Review
  3. Clinical features and visual outcomes of ocular sarcoidosis at a tertiary referral center in Tokyo.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2022
    Article
  4. Progress in the diagnosis of ocular sarcoidosis.Indian journal of ophthalmology · 2022
    Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Kei TakayamaDepartment of Ophthalmology, National Defense Medical College, Tokorozawa, Japan.
Kozo HarimotoDepartment of Ophthalmology, National Defense Medical College, Tokorozawa, Japan.
Tomohito SatoDepartment of Ophthalmology, National Defense Medical College, Tokorozawa, Japan.
Yutaka SakuraiDepartment of Ophthalmology, National Defense Medical College, Tokorozawa, Japan.
Manzo TaguchiDepartment of Ophthalmology, National Defense Medical College, Tokorozawa, Japan.
Takayuki KandaDepartment of Ophthalmology, National Defense Medical College, Tokorozawa, Japan.
Masaru TakeuchiDepartment of Ophthalmology, National Defense Medical College, Tokorozawa, Japan.ORCID 0000-0002-4913-7089
National Defense Medical College · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The distribution of age at diagnosis in ocular sarcoidosis has shifted towards the older age groups in developed countries. In systemic sarcoidosis, age-related differences in the clinical presentation, which reflect the therapeutic strategies, was reported. We retrospectively compared 100 consecutive patients from April 2010 to March 2016 who were initially diagnosed with ocular sarcoidosis by International Workshop on Ocular Sarcoidosis criteria. They were classified into elder (>65 years: 50 patients) and younger (≤65 years: 50 patients) groups by the age at diagnosis of uveitis associated with sarcoidosis. All patients received ophthalmic examination to assess the presence of seven intraocular signs and 4 laboratory parameters. Significantly fewer ocular signs (2.8 ± 1.5 and 3.6 ± 1.5; P = 0.0034) and abnormal laboratory results (1.5 ± 1.2 and 2.0 ± 1.2; P = 0.023) were detected in the elder group than in the younger group; statistical differences were found between the groups regarding the frequencies of mutton-fat keratic precipitates (40% and 64%; P = 0.012), vitreous opacities (60% and 78%; P = 0.0059), bilateral inflammation (64% and 80%; P = 0.012), and bilateral hilar lymphadenopathy between the groups (52% and 78%; P < 0.001). Multiple linear regression analysis showed negative correlations between age and number of detected ocular signs (r = -0.36, P < 0.001) and laboratory results (r = -0.20, P = 0.023). The characteristic ocular signs and abnormal laboratory results had a lower frequency in the elder patients compared with the younger patients. Probable or possible ocular sarcoidosis by the international criteria should increase with increased life expectancy in developed countries.

Indexed as

AdultAgingBiopsyEndophthalmitisEye DiseasesFemaleHumansMaleMiddle AgedRetrospective StudiesSarcoidosisUveitisVision, OcularVitreous Body

Identifiers

PMID30138345
PMCPMC6107189
OpenAlexW2888738836

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.